GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » EV-to-EBIT

Ansell (Ansell) EV-to-EBIT : 17.15 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Ansell EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ansell's Enterprise Value is $2,658 Mil. Ansell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $155 Mil. Therefore, Ansell's EV-to-EBIT for today is 17.15.

The historical rank and industry rank for Ansell's EV-to-EBIT or its related term are showing as below:

ANSLF' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.14   Med: 15.41   Max: 47.82
Current: 17.52

During the past 13 years, the highest EV-to-EBIT of Ansell was 47.82. The lowest was 7.14. And the median was 15.41.

ANSLF's EV-to-EBIT is ranked better than
56.74% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.215 vs ANSLF: 17.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ansell's Enterprise Value for the quarter that ended in Dec. 2023 was $2,416 Mil. Ansell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $155 Mil. Ansell's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.42%.


Ansell EV-to-EBIT Historical Data

The historical data trend for Ansell's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell EV-to-EBIT Chart

Ansell Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.91 15.40 13.41 9.98 12.60

Ansell Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.98 - 12.60 -

Competitive Comparison of Ansell's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Ansell's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ansell's EV-to-EBIT falls into.



Ansell EV-to-EBIT Calculation

Ansell's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2658.179/155
=17.15

Ansell's current Enterprise Value is $2,658 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell  (OTCPK:ANSLF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ansell's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=155/2415.51686
=6.42 %

Ansell's Enterprise Value for the quarter that ended in Dec. 2023 was $2,416 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ansell's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell (Ansell) Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA 02-22-2019